ATE161185T1 - Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor - Google Patents

Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor

Info

Publication number
ATE161185T1
ATE161185T1 AT93916011T AT93916011T ATE161185T1 AT E161185 T1 ATE161185 T1 AT E161185T1 AT 93916011 T AT93916011 T AT 93916011T AT 93916011 T AT93916011 T AT 93916011T AT E161185 T1 ATE161185 T1 AT E161185T1
Authority
AT
Austria
Prior art keywords
stimulating factor
administration
pct
granulocyte colony
factor solution
Prior art date
Application number
AT93916011T
Other languages
English (en)
Inventor
Anne Bousseau
Armand Frydman
Jean-Paul Plard
Gilles Spenlehauer
Michel Veillard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9432170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE161185(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of ATE161185T1 publication Critical patent/ATE161185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AT93916011T 1992-07-23 1993-07-19 Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor ATE161185T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929209079A FR2693907B1 (fr) 1992-07-23 1992-07-23 Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.

Publications (1)

Publication Number Publication Date
ATE161185T1 true ATE161185T1 (de) 1998-01-15

Family

ID=9432170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916011T ATE161185T1 (de) 1992-07-23 1993-07-19 Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor

Country Status (11)

Country Link
US (1) US5554150A (de)
EP (1) EP0651649B1 (de)
JP (1) JPH07509696A (de)
AT (1) ATE161185T1 (de)
CA (1) CA2140445A1 (de)
DE (1) DE69315840T2 (de)
DK (1) DK0651649T3 (de)
ES (1) ES2110104T3 (de)
FR (1) FR2693907B1 (de)
GR (1) GR3025713T3 (de)
WO (1) WO1994002164A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69521880T2 (de) * 1994-02-08 2002-01-03 Amgen Inc., Thousand Oaks Orales verabreichungssystem von chemischmodifizierten proteinen g-csf
US5865840A (en) * 1997-10-22 1999-02-02 Light Sciences Limited Partnership Enhancement of light activation effect by immune augmentation
ATE269716T1 (de) 2000-02-29 2004-07-15 Pfizer Prod Inc Stabilisierter granulozyten-kolonie- stimulierender faktor
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8305206A (pt) * 1982-09-28 1984-05-02 Sds Biotech Corp Processo e preparacao para promover o crescimento e melhorar o rendimento da alimentacao de animais
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
US5186931A (en) * 1986-08-06 1993-02-16 Ajinomoto Co., Inc. Composition and method for supporting bone marrow transplantation
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
CA1339071C (en) * 1988-08-24 1997-07-29 Koichiro Tsuji Thrombus control agent
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5241072A (en) * 1990-05-25 1993-08-31 Genzyne Corporation Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid

Also Published As

Publication number Publication date
GR3025713T3 (en) 1998-03-31
CA2140445A1 (fr) 1994-02-03
FR2693907A1 (fr) 1994-01-28
EP0651649A1 (de) 1995-05-10
ES2110104T3 (es) 1998-02-01
DE69315840D1 (de) 1998-01-29
DE69315840T2 (de) 1998-04-30
US5554150A (en) 1996-09-10
DK0651649T3 (da) 1998-01-19
FR2693907B1 (fr) 1994-09-02
WO1994002164A1 (fr) 1994-02-03
JPH07509696A (ja) 1995-10-26
EP0651649B1 (de) 1997-12-17

Similar Documents

Publication Publication Date Title
IT1261949B (it) Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo.
DE69333607D1 (de) Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE3583008D1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
DE3750619D1 (de) System zur Abgabe von Arzneistoffen.
NZ220178A (en) Pulsatile drug delivery system
NO924672D0 (no) Metode for fremstilling av interferon alfa-2-krystaller
AU102141S (en) Nasal spray pump
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
DE3789673D1 (de) Selbstansaugendes Zufuhrsystem zur Verabreichung eines Heilmittels.
EP0322504A3 (en) Shrouded inducer pump
DE69315840D1 (de) Verfahren zur verabreichung einer lösung von granulozyten-kolonie-stimulierendem faktor
FI924724A7 (fi) Parannettu menetelmä lääkkeen antamiseksi iontoforeesilla
ATE311897T1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
DE69218200D1 (de) Behandlung von leberkrebs
FI951759A0 (fi) Menetelmä 2,2-difluoriketeenisilyyli-O,S-asetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihapon O,S-estereiden valmistamiseksi
IT8819821A0 (it) Ugello per pompa di dispositivi iniettori di carburante.
SE9002731D0 (sv) Product comprising growth factor
GB2260702B (en) Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
ATE209042T1 (de) Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen
NZ333150A (en) di-hydrated lysine salt of N,N'-diacetylcystine and medicaments
IT233634Y1 (it) Tavoletta filtro per cannule di gruppi di aspirazione dentistici.
EP0296227A4 (de) Verabreichung von aminosäuren durch die nase.
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят
CY2019A (en) The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients

Legal Events

Date Code Title Description
RZN Patent revoked